JBNB  Vol.4 No.2 , April 2013
Evaluation of the Controlled Release Ability of Theophylline from Xanthan/Chondroitin Sulfate Hydrogels

The xanthan/chondroitin sulfate (X/CS) hydrogels, obtained by a crosslinking technique, were evaluated in vitro and in vivo as matrices for theophylline release. The influence of pH of simulated physiological media on the X/CS swelling behaviour at 37°C was investigated. The hydrogels theophylline loading degree was evaluated by near infrared chemical imaging (NIR-CI) technique and confirmed also by FT-IR spectroscopy; the drug loading was about 77.5% based on PLS-DA prediction (Partial least squares-Discriminate Analysis). The release profiles of theophylline from X/CS hydrogels in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) depend on CS content. The release mechanisms were controlled by the drug solubility and ionic properties of the polymers. In vivo theophylline delivery was done by oral administration. Pharmacokinetic analysis revealed sustained-release characteristics for 50/50 X/CS theophylline-loaded formulation compared with raw theophylline which was rapidly absorbed, distributed and eliminated. A good in vitro-in vivo correlation was found.

Cite this paper: A. Oprea, M. Nistor, L. Profire, M. Popa, C. Lupusoru and C. Vasile, "Evaluation of the Controlled Release Ability of Theophylline from Xanthan/Chondroitin Sulfate Hydrogels," Journal of Biomaterials and Nanobiotechnology, Vol. 4 No. 2, 2013, pp. 123-131. doi: 10.4236/jbnb.2013.42017.

[1]   T. R. Reddy, D. Dhachinamoorthi and K. B. Chandrasekhara, “Independent Release Behavior of Glipizide Matrix Release Tablets Containing Chitosan and Xanthan Gum,” International Journal of Pharmaceutical and Biomedical Research, Vol. 1, No. 2, 2010, pp. 64-70.

[2]   J. V. Gruber, “Polysaccharide-Based Polymers in Cosmetics,” In: E. D. Goddard and J. V. Gruber, Eds., Principles of Polymer Science and Technology in Cosmetics and Personal Care, Marcel Dekker, New York, 1999, pp. 339-403.

[3]   A. A. Salyers, J. R. Vercellotti, S. E. West and T. D. Wilkins, “Fermentation of Mucin and Plant Polysaccharides by Strains of Bacteroides from the Human Colon,” Applied and Environmental Microbiology, Vol. 33, No. 2, 1977, pp. 319-322.

[4]   K. Wang, J. Fan, Y. Liu and Z. He, “Konjac Glucomannan and Xanthan Gum as Compression Coat for Colonic Drug Delivery: Experimental and Theoretical Evaluations,” Frontiers of Chemical Engineering in China, Vol. 4, No. 1, 2010, pp. 102-108. doi:10.1007/s11705-009-0299-x

[5]   T. Quinten, T. De Beer, F. O. Onofre, G. Mendez-Montealvo, Y. J. Wang, J. P. Remon and C. Vervaet, “Sustained-Release and Swelling Characteristics of Xanthan Gum/Ethylcellulose-Based Injection Moulded Matrix Tablets: In Vitro and in Vivo Evaluation,” Journal of Pharmaceutical Sciences, Vol. 100, No. 7, 2011, pp. 28582870. doi:10.1002/jps.22480

[6]   J. Mor and A. Nanda, “Formulation and Evaluation of a Colon Targeted Drug Delivery System Using Ibuprofen as a Model Drug,” The Pharmaceutical Research, Vol. 5, No. 1, 2011, pp. 176-183.

[7]   W. Darunkaisorn and T. Phaechamud, “Sustained Release of Propranolol HCl Using Matrix Granule Comprising Wax and Polymers,” Research Journal of Pharmaceutical, Biological and Chemical Sciences, Vol. 2, No. 1, 2011, pp. 158-166.

[8]   M. M. Talukdar and R. Kinget, “Comparative Study on Xanthan Gum and Hydroxypropylmethyl Cellulose as Matrices for Controlled-Release Drug Delivery. II. Drug Diffusion in Hydrated Matrices,” International Journal of Pharmaceutics, Vol. 151, No. 1, 1997, pp. 99-107. doi:10.1016/S0378-5173(97)04896-5

[9]   C. César, S. Nogueira, L. M. Cabral, T. C. Dos Santos, A. Marucci and F. Alhaique, “Evaluation of New Polysaccharides Networks for Extended-Release Purposes: Mesquite Seed Gum (MSG), Xanthan Gum and Chitosan,” Brazilian Journal of Pharmaceutical Sciences, Vol. 39, No. 3, 2003, pp. 273-288.

[10]   E. Verhoeven, C. Vervaet and J. P. Remon, “Xanthan Gum to Tailor Drug Release of Sustained-Release Ethylcellulose Mini-Matrices Prepared via Hot-Melt Extrusion: In Vitro and in Vivo Evaluation,” European Journal of Pharmaceutics and Biopharmaceutics, Vol. 63, No. 3, 2006, pp. 320-330. doi:10.1016/j.ejpb.2005.12.004

[11]   C. T. Lee, P. H. Kung and Y. D. Lee, “Preparation of Poly(Vinyl Alcohol)-Chondroitin Sulphate Hydrogel as Matrices in Tissue Engineering,” Carbohydrate Polymers, Vol. 61, 2005, pp. 348-354. doi:10.1016/j.carbpol.2005.06.018

[12]   L. Huang, W. Sui, Y. Wang and Q. Jiao, “Preparation of Chitosan/Chondroitin Sulfate Complex Microcapsules and Application in Controlled Release of 5-Fluorouracil,” Carbohydrate Polymers, Vol. 80, No. 1, 2010, pp. 168173. doi:10.1016/j.carbpol.2009.11.007

[13]   K. Kofuji, T. Ito, Y. Murata and S. Kawashima, “Effect of Chondroitin Sulfate on the Biodegradation and Drug Release of Chitosan Gel Beads in Subcutaneous Air Pouches of Mice,” Biological and Pharmaceutical Bulletin, Vol. 25, No. 2, 2002, pp. 268-271. doi:10.1248/bpb.25.268

[14]   E. C. Muniz, E. G. Crispim, A. R. Fajardo, J. F. Piai, E. R. F. Ramos, T. U. Nakamura, C. V. Nakamura and A. F. Rubira, “Hydrogels Based on Chemically Modified Poly (Vinyl Alcohol) (PVA-GMA) and PVA-GMA/Chondroitin Sulfate: Preparation and Characterization,” Express Polymer Letters, Vol. 6, No. 5, 2012, pp. 383-395.

[15]   A. M. Oprea, A. Neamtu and C. Vasile, “Xanthan/Chondroitin Sulfate Hydrogels as Carrier for Drug Delivery Applications,” Sectiunea Genetica si Biologie Moleculara, Vol. 12, No. 2, 2011, pp. 97-102.

[16]   N. Popa, O. Novac, L. Profire, C. E. Lupusoru and M. I. Popa, “Hydrogels Based on Chitosan-Xanthan for Controlled Release of Theophylline,” Journal of Materials Science: Materials in Medicine, Vol. 21, No. 4, 2010, pp. 1241-1248. doi:10.1007/s10856-009-3937-4

[17]   R. W. Korsmeyer, S. R. Lusting and N. A. Peppas, “Solute and Penetrant Diffusion in Swellable Polymers. I. Mathematical Modeling,” Journal of Polymer Science Part B: Polymer Physics, Vol. 24, No. 2, 1986, pp. 395408. doi:10.1002/polb.1986.090240214

[18]   R. W. Korsmeyer and N. A. Peppas, “Solute and Penetrant Diffusion in Swellable Polymers. III. Drug Release from Glassy Poly (HEMA-co-NVP) Copolymers,” Journal of Controlled Release, Vol. 1, No. 2, 1984, pp. 89-98. doi:10.1016/0168-3659(84)90001-4

[19]   A. Kostic, B. Adnadjevic, A. Popovic and J. Jovanovic, “Comparison of the Swelling Kinetics of a Partially Neutralized Poly (Acrylic Acid) Hydrogel in Distilled Water and Physiological Solution,” Journal of the Serbian Chemical Society, Vol. 72, No. 11, 2007, pp. 1139-1153. doi:10.2298/JSC0711139K

[20]   L. Serra, J. Doménech and N. A. Peppas, “Drug Transport Mechanisms and Release Kinetics from Molecularly Designed Poly(Acrylic Acid-G-Ethylene Glycol) Hydrogels,” Biomaterials, Vol. 27, No. 31, 2006, pp. 5440-5451. doi:10.1016/j.biomaterials.2006.06.011

[21]   M. Zimmermann, “Ethical Guidelines for Investigations of Experimental Pain in Conscious Animals,” Pain, Vol. 16, No. 2, 1983, pp. 109-110. doi:10.1016/0304-3959(83)90201-4

[22]   N. Labacevski, D. Zendelovska, O. Sibinovska, S. Simeska, I. Kikerkov, P. Milosevski and S. Petrov, “Development and Validation of the HPLC Method for the Determination of Theophylline Serum Concentration: A Comparison with FPIA Method and Its Application for Bioequivalence Study,” Bulletin of Chemists and Technologists of Macedonia, Vol. 22, No. 2, 2003, pp. 97-104.

[23]   J. L. Johnson, J. Holinej and M. D. Williams, “Influence of Ionis Strength on Matrix Integrity and Drug Release from Hydroxypropyl Cellulose Compacts,” International Journal of Pharmaceutics, Vol. 90, No. 2, 1993, pp. 151159. doi:10.1016/0378-5173(93)90151-5

[24]   T. Solomon, “The Definition and Unit of Ionic Strength,” Journal of Chemical Education, Vol. 78, No. 12, 2001, pp. 1691-1692. doi:10.1021/ed078p1691

[25]   A. G. Andreopoulos and P. A. Tarantili, “Xanthan Gum as a Carrier for Controlled Release of Drugs,” Journal of Biomaterials Applications, Vol. 16, No. 1, 2001, pp. 3446. doi:10.1106/XBFG-FYFX-9TW9-M83U

[26]   M. C. Cohel and S. H. Bariya, “Fabrication of TripleLayer Matrix Tablets of Venlafaxine Hydrochloride Using Xanthan Gum,” AAPS PharmSciTech, Vol. 10, No. 2, 2009, pp. 624-630. doi:10.1208/s12249-009-9244-z

[27]   R. Chereson, “Bioavailability, Bioeqiuvalence and Drug Selection,” In: C. M. Makoid, P. J. Vuchetich and U. V. Banakar, Eds., Basic Pharmacokinetics, The Virtual University Press, 1996, pp. 1-111.